Incentives for drug development--the curious case of colchicine.
Kesselheim
Aaron S
AS
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, and Harvard Medical School, Boston, USA.
Solomon
Daniel H
DH
D015210:Arthritis, Gouty / Q000188:drug therapy; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use*; D017277:Drug Approval / Q000266:history; D055808:Drug Discovery / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence; D010505:Familial Mediterranean Fever / Q000188:drug therapy*; D006073:Gout / Q000188:drug therapy*; D049673:History, 20th Century; D006801:Humans; D007880:Legislation, Drug; D009965:Orphan Drug Production / Q000266:history / Q000331:legislation & jurisprudence*; D010330:Patents as Topic; D014481:United States; D014486:United States Food and Drug Administration
D003078:Colchicine